YCW26· AICellType
The agentic drug company. We simulate human biology.
Founders
- David van DijkFounder/CEO
- Ivan VrkicFounder/CTO
Same space
Competitors
Closest in what they build, same category.
Parallel BioS21Using the immune system to cure diseaseShared: biology, drug, humanActive
Output BiosciencesS21The foundation for the next era of biologyShared: biology, biological, foundationActive
Verge GenomicsS15We use human data and AI to develop better drugs faster.Shared: biology, drug, humanActive
Strand AIW26Multimodal foundation models to predict uncollected patient biologyShared: biology, drug, foundationActive
Tamarind BioW24AI Inference Platform for Drug DiscoveryShared: simulate, biology, drugActive
Adjacent
Overlapping tags, a different niche.
Synthetic SocietyS25Synthetic Videos to Simulate Real UsersShared: simulateActive
Numerion LabsW15Artificial intelligence for drug discovery.Shared: biology, drug, discoveryActive
AbInitio BioX26The Intelligence layer for Drug ManufacturingShared: drug, validated, pharmaActive
Sequence BioS19Discovering the true signals of disease to power life-changing drugs.Shared: drug, signal, discoveryActive
Rosebud BiosciencesW22Growing micro-organs to find new drugsShared: drug, validated, discoveryActive
Also from W26 in AI
Batchmates in Winter 2026.
/dev/fastW26/dev/fast is the AI-native code forgeActive
10x ScienceW26The AI-native platform for next-generation protein characterization.Active
21stW26UI building blocks for the agentic internetActive
AemonW26The Forward-Deployed AI Research EngineerActive
Agentic FabriqW26The control plane for AI agents.Active
Alt-XW26Building the best venue for private markets exposure.Active
About CellType
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
New York City, NY, USA
CellType: questions
Which YC batch was CellType in?
CellType was in Y Combinator's Winter 2026 batch (W26).
Is CellType still active?
Y Combinator lists CellType as active.
Who founded CellType?
CellType's founders, as listed on its YC page: David van Dijk (Founder/CEO), Ivan Vrkic (Founder/CTO).
Where is CellType based?
CellType lists New York City, NY, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.